These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10961615)

  • 1. Fenfluramine blocks low-Mg2+-induced epileptiform activity in rat entorhinal cortex.
    Gentsch K; Heinemann U; Schmitz B; Behr J
    Epilepsia; 2000 Aug; 41(8):925-8. PubMed ID: 10961615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent depression of stimulus evoked field potential responses in the medial entorhinal cortex by serotonin.
    Schmitz D; Gloveli T; Empson RM; Heinemann U
    Br J Pharmacol; 1999 Sep; 128(1):248-54. PubMed ID: 10498859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
    Romero L; Artigas F
    J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices.
    Armand V; Rundfeldt C; Heinemann U
    Epilepsia; 2000 Jan; 41(1):28-33. PubMed ID: 10643920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine.
    Hume S; Hirani E; Opacka-Juffry J; Myers R; Townsend C; Pike V; Grasby P
    Synapse; 2001 Aug; 41(2):150-9. PubMed ID: 11400181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
    Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T
    J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM; Perry KW; Wong DT
    Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin blocks different patterns of low Mg2+-induced epileptiform activity in rat entorhinal cortex, but not hippocampus.
    Schmitz D; Empson RM; Gloveli T; Heinemann U
    Neuroscience; 1997 Jan; 76(2):449-58. PubMed ID: 9015329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin increases GABA release in rat entorhinal cortex by inhibiting interneuron TASK-3 K+ channels.
    Deng PY; Lei S
    Mol Cell Neurosci; 2008 Oct; 39(2):273-84. PubMed ID: 18687403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction.
    Harsing LG; Prauda I; Barkoczy J; Matyus P; Juranyi Z
    Neurochem Res; 2004 Aug; 29(8):1487-97. PubMed ID: 15260125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
    Udo de Haes JI; Cremers TI; Bosker FJ; Postema F; Tiemersma-Wegman TD; den Boer JA
    Neuropsychopharmacology; 2005 Sep; 30(9):1624-31. PubMed ID: 15827572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of valproate and trans-2-en-valproate on different forms of epileptiform activity in rat hippocampal and temporal cortex slices.
    Sokolova S; Schmitz D; Zhang CL; Löscher W; Heinemann U
    Epilepsia; 1998 Mar; 39(3):251-8. PubMed ID: 9578041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.